The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates

被引:100
|
作者
Chen, Kuangqi [1 ]
Li, Yanqing [1 ]
Zhang, Xuhong [1 ]
Ullah, Rahim [2 ]
Tong, Jianping [1 ]
Shen, Ye [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Ophthalmol, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Endocrinol,Natl Clin Res Ctr Child Hlth, Hangzhou 310052, Zhejiang, Peoples R China
关键词
GROWTH-FACTOR RECEPTOR; OXYGEN SPECIES ROS; SUBSTANCE-P; DRY EYE; INFLAMMASOME ACTIVATION; EGFR TRANSACTIVATION; HYDROGEN-PEROXIDE; CELL-MIGRATION; MOUSE MODEL; ER STRESS;
D O I
10.1038/s41419-022-04963-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Phosphatidylinositol 3 kinase (PI3K)/AKT (also called protein kinase B, PKB) signalling regulates various cellular processes, such as apoptosis, cell proliferation, the cell cycle, protein synthesis, glucose metabolism, and telomere activity. Corneal epithelial cells (CECs) are the outermost cells of the cornea; they maintain good optical performance and act as a physical and immune barrier. Various growth factors, including epidermal growth factor receptor (EGFR) ligands, insulin-like growth factor 1 (IGF1), neurokinin 1 (NK-1), and insulin activate the PI3K/AKT signalling pathway by binding their receptors and promote antiapoptotic, anti-inflammatory, proliferative, and migratory functions and wound healing in the corneal epithelium (CE). Reactive oxygen species (ROS) regulate apoptosis and inflammation in CECs in a concentration-dependent manner. Extreme environments induce excess ROS accumulation, inhibit PI3K/AKT, and cause apoptosis and inflammation in CECs. However, at low or moderate levels, ROS activate PI3K/AKT signalling, inhibiting apoptosis and stimulating proliferation of healthy CECs. Diabetes-associated hyperglycaemia directly inhibit PI3K/AKT signalling by increasing ROS and endoplasmic reticulum (ER) stress levels or suppressing the expression of growth factors receptors and cause diabetic keratopathy (DK) in CECs. Similarly, hyperosmolarity and ROS accumulation suppress PI3K/AKT signalling in dry eye disease (DED). However, significant overactivation of the PI3K/AKT signalling pathway, which mediates inflammation in CECs, is observed in both infectious and noninfectious keratitis. Overall, upon activation by growth factors and NK-1, PI3K/AKT signalling promotes the proliferation, migration, and anti-apoptosis of CECs, and these processes can be regulated by ROS in a concentration-dependent manner. Moreover, PI3K/AKT signalling pathway is inhibited in CECs from individuals with DK and DED, but is overactivated by keratitis.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Role of the PI3K/AKT (mTOR and GSK3β) signalling pathway and photobiomodulation in diabetic wound healing
    Jere, Sandy W.
    Houreld, Nicolette N.
    Abrahamse, Heidi
    CYTOKINE & GROWTH FACTOR REVIEWS, 2019, 50 : 52 - 59
  • [22] The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
    Zhang, Lifang
    Wu, Jianhong
    Ling, Ming Tat
    Zhao, Liang
    Zhao, Kong-Nan
    MOLECULAR CANCER, 2015, 14
  • [23] The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
    Lifang Zhang
    Jianhong Wu
    Ming Tat Ling
    Liang Zhao
    Kong-Nan Zhao
    Molecular Cancer, 14
  • [24] Recent Updates on Morpholino Pyrimidine Derivatives as Promising PI3K/Akt/mTOR Inhibitors
    Keertika, Khandelwal
    Behera, Swagatika
    Sharma, Nutan
    CHEMISTRY AFRICA-A JOURNAL OF THE TUNISIAN CHEMICAL SOCIETY, 2025, 8 (02): : 369 - 395
  • [25] PI3K/Akt Pathway Mutations in Retinoblastoma
    Cohen, Yoram
    Merhavi-Shoham, Efrat
    Avraham-Lubin, Bat Chen R.
    Savetsky, Michael
    Frenkel, Shahar
    Pe'er, Jacob
    Goldenberg-Cohen, Nitza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (11) : 5054 - 5056
  • [26] PI3K/AKT/mTOR pathway in angiogenesis
    Karar, Jayashree
    Maity, Amit
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2011, 4
  • [27] Activation of the PI3K/Akt pathway in neuroblastoma
    Sartelet, Herve
    Castaing, Marine
    Fabre, Monique
    Bosq, Jacques
    Rougemont, Anne-Laure
    Michieis, Stefan
    Vassal, Gilles
    VIRCHOWS ARCHIV, 2007, 451 (02) : 130 - 130
  • [28] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [29] Activation of the PI3K/Akt pathway in neuroblastoma
    Sartelet, H.
    Castain, M.
    Fabre, M.
    Bosq, J.
    Rougemont, A.
    Michiels, S.
    Vassal, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Overview of the PI3K/Akt/mTOR pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2008, 19 : 21 - 21